Jacobs Levy Equity Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-52,071
| Closed | -$3.66M | – | 944 |
|
|
2024
Q3 | $3.66M | Buy |
+52,071
| New | +$3.66M | 0.01% | 496 |
|
|
2021
Q3 | – | Sell |
-128,121
| Closed | -$10.7M | – | 1037 |
|
|
2021
Q2 | $10.7M | Sell |
128,121
-98,590
| -43% | -$8.23M | 0.07% | 280 |
|
|
2021
Q1 | $17.1M | Buy |
226,711
+31,602
| +16% | +$2.39M | 0.13% | 197 |
|
|
2020
Q4 | $17.1M | Buy |
195,109
+3,736
| +2% | +$328K | 0.15% | 167 |
|
|
2020
Q3 | $14.6M | Buy |
+191,373
| New | +$14.6M | 0.15% | 153 |
|
|
2019
Q3 | – | Sell |
-104,970
| Closed | -$8.99M | – | 922 |
|
|
2019
Q2 | $8.99M | Buy |
104,970
+41,856
| +66% | +$3.59M | 0.12% | 208 |
|
|
2019
Q1 | $5.61M | Buy |
+63,114
| New | +$5.61M | 0.08% | 309 |
|
|
2018
Q1 | – | Sell |
-4,450
| Closed | -$397K | – | 1003 |
|
|
2017
Q4 | $397K | Sell |
4,450
-220
| -5% | -$19.6K | 0.01% | 797 |
|
|
2017
Q3 | $435K | Buy |
+4,670
| New | +$435K | 0.01% | 729 |
|
|
2015
Q4 | – | Sell |
-24,320
| Closed | -$2.56M | – | 811 |
|
|
2015
Q3 | $2.56M | Sell |
24,320
-76,255
| -76% | -$8.03M | 0.05% | 309 |
|
|
2015
Q2 | $13.8M | Buy |
100,575
+70,600
| +236% | +$9.66M | 0.26% | 127 |
|
|
2015
Q1 | $3.74M | Buy |
+29,975
| New | +$3.74M | 0.06% | 268 |
|